Home / Business and Economy / Judge Limits Ketamine Questions in Musk vs. OpenAI Trial
Judge Limits Ketamine Questions in Musk vs. OpenAI Trial
14 Mar
Summary
- Judge Rogers set trial boundaries, excluding Musk's ketamine use.
- Musk seeks up to $134 billion in damages from OpenAI and Microsoft.
- Trial date is set for April 28, featuring prominent AI figures.
The upcoming trial between Elon Musk and OpenAI, along with Microsoft, will largely exclude discussions of Musk's alleged ketamine use. US District Judge Yvonne Gonzalez Rogers ruled on Friday in Oakland, California, that such questioning is irrelevant unless more evidence of its effects during key times is presented.
The trial, scheduled to commence on April 28, will delve into OpenAI's founding a decade ago and Musk's subsequent departure. Musk is pursuing damages totaling up to $134 billion from the generative AI company and Microsoft, alleging they defrauded him by deviating from their nonprofit mission. OpenAI and Microsoft have denied these claims.
